Oric Pharmaceuticals Inc — Quarterly Dividends (NASDAQ:ORIC) | MetaTrader

Open full chart

Notizie

H.C. Wainwright alza il target su ORIC Pharmaceuticals per progressi negli studi

H.C. Wainwright raises ORIC Pharmaceuticals price target on trial progress

Oppenheimer conferma rating Outperform su ORIC, target $15

Oppenheimer reiterates Outperform on ORIC stock, $15 target

Oric Pharmaceuticals presenta nuovo prospetto per offerta at-the-market da 200 milioni di dollari

Oric Pharmaceuticals files new $200 million at-the-market offering prospectus

Il direttore di Oric Pharmaceuticals Heyman vende azioni per un valore di $80.430

Oric Pharmaceuticals director Heyman sells shares worth $80,430

ORIC: Transition To Late-Stage Development Presents Upside (NASDAQ:ORIC)

Oric Pharmaceuticals Stock Sees Healthy RS Rating Jump To 80

H.C. Wainwright conferma il rating Buy sulle azioni ORIC Pharmaceuticals

H.C. Wainwright reiterates Buy rating on ORIC Pharmaceuticals stock